6R-BH4 Pulmonary Arterial Hypertension Study
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
6R-BH4 Pulmonary Arterial Hypertension Study is a clinical trial[1].
Key Facts
- 6R-BH4 Pulmonary Arterial Hypertension Study is in the country of United States[2].
- 6R-BH4 Pulmonary Arterial Hypertension Study's instance of is recorded as clinical trial[3].
- 6R-BH4 Pulmonary Arterial Hypertension Study's start time is recorded as +2008-03-31T00:00:00Z[4].
- 6R-BH4 Pulmonary Arterial Hypertension Study's end time is recorded as +2008-09-30T00:00:00Z[5].
- 6R-BH4 Pulmonary Arterial Hypertension Study's contributor to the creative work or subject is recorded as BioMarin Pharmaceutical[6].
- 6R-BH4 Pulmonary Arterial Hypertension Study's main subject is recorded as arterial hypertension[7].
- 6R-BH4 Pulmonary Arterial Hypertension Study's number of participants is recorded as {'unit': '1', 'amount': '+14'}[8].
- 6R-BH4 Pulmonary Arterial Hypertension Study's title is recorded as A Phase 1, Multicenter, Open-label, Dose-escalation Study to Evaluate the Safety and Efficacy of 6R-BH4 in Subjects With Pulmonary Arterial Hypertension[9].
- 6R-BH4 Pulmonary Arterial Hypertension Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- 6R-BH4 Pulmonary Arterial Hypertension Study's ClinicalTrials.gov ID is recorded as NCT00435331[11].
- 6R-BH4 Pulmonary Arterial Hypertension Study's research intervention is recorded as verapamil[12].
- 6R-BH4 Pulmonary Arterial Hypertension Study's clinical trial phase is recorded as phase I clinical trial[13].
- 6R-BH4 Pulmonary Arterial Hypertension Study's research site is recorded as Vanderbilt University[14].
- 6R-BH4 Pulmonary Arterial Hypertension Study's principal investigator is recorded as Ivan M. Robbins[15].
- 6R-BH4 Pulmonary Arterial Hypertension Study's study type is recorded as interventional study[16].